Trinity Biotech plc announced John Gillard as President and CEO, while Paul Tivnan was appointed Non-Executive Director.
3 reports, 1 independent
Updated Aug 21
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trinity Biotech plc announced John Gillard as President and CEO, while Paul Tivnan was appointed Non-Executive Director.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
John Gillard
Nothing else this week.
-
Brookfield Corporation
asset management company based in Canada
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireTrinity Biotech Appoints Paul Tivnan as Non-Executive Director DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human
- GlobeNewswireTrinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor Clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to commercial
- Unknown outlet